Highlights and Quick Summary
- Change in payables and accrued liability for the quarter ending November 30, 2022 was $-5.86 Million (a -733.86% decrease compared to previous quarter)
- Year-over-year quarterly Change in payables and accrued liability increased by 415.07%
- Annual Change in payables and accrued liability for 2022 was $9.27 Million (a 466.65% increase from previous year)
- Annual Change in payables and accrued liability for 2021 was $1.64 Million (a -107.66% decrease from previous year)
- Annual Change in payables and accrued liability for 2020 was $-21.4 Million (a -369.1% decrease from previous year)
- Twelve month Change in payables and accrued liability ending November 30, 2022 was $3.21 Million (a -66.29% decrease compared to previous quarter)
- Twelve month trailing Change in payables and accrued liability decreased by -22.84% year-over-year
Trailing Change in payables and accrued liability for the last four month:
| 30 Nov '22 | 31 Aug '22 | 31 May '22 | 28 Feb '22 |
|---|---|---|---|
| $3.21 Million | $9.53 Million | $9.83 Million | $4.16 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Change in payables and accrued liability of Organigram Holdings Inc.
Most recent Change in payables and accrued liabilityof OGI including historical data for past 10 years.Interactive Chart of Change in payables and accrued liability of Organigram Holdings Inc.
Organigram Holdings Inc. Change in payables and accrued liability for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-5.86 | $0.93 | $9.29 | $-1.14 | $9.27 |
| 2021 | $0.45 | $1.23 | $3.62 | $-2.81 | $1.64 |
| 2020 | $-0.25 | $-17.88 | $7.95 | $-3.38 | $-21.37 |
| 2019 | – | – | – | – | $7.94 |
| 2018 | – | – | – | – | $3.06 |
| 2017 | – | – | – | – | $0.53 |
| 2016 | – | – | – | – | $0.5 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic